Similar articles

• Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.

  Wheelock JB, Krebs HB, Goplerud DR, Myers M. Wheelock JB, et al. Obstet Gynecol. 1985 Sep;66(3):410-2. Obstet Gynecol. 1985. PMID: 4040622
• Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.

  Long HJ 3rd, Cross WG, Wieand HS, Webb MJ, Mailliard JA, Kugler JW, Tschetter LK, Kardinal CG, Ebbert LP, Rayson S. Long HJ 3rd, et al. Gynecol Oncol. 1995 May;57(2):235-9. doi: 10.1006/gyno.1995.1132. Gynecol Oncol. 1995. PMID: 7729741 Clinical Trial.
• Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.

  Vogl SE, Seltzer V, Camacho F, Davis TE. Vogl SE, et al. J Reprod Med. 1986 May;31(5):327-9. J Reprod Med. 1986. PMID: 2427717 No abstract available.
• Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.

  Dunst J, Haensgen G. Dunst J, et al. Strahlenther Onkol. 2001 Dec;177(12):635-40. Strahlenther Onkol. 2001. PMID: 11789401 Review.
• [Clinical evaluation of chemoradiotherapy for advanced cervical cancer].

  Kaneyasu Y, Okawa MK, Okawa T. Kaneyasu Y, et al. Gan To Kagaku Ryoho. 1997 Nov;24(14):2084-91. Gan To Kagaku Ryoho. 1997. PMID: 9388517 Review. Japanese.